| Primary |
| Erectile Dysfunction |
78.4% |
| Hypertension |
6.6% |
| Diabetes Mellitus |
2.4% |
| Benign Prostatic Hyperplasia |
2.1% |
| Product Used For Unknown Indication |
1.6% |
| Blood Pressure |
1.3% |
| Sexual Dysfunction |
0.9% |
| Prostatectomy |
0.7% |
| Hypercholesterolaemia |
0.6% |
| Blood Cholesterol |
0.5% |
| Blood Cholesterol Increased |
0.5% |
| Depression |
0.5% |
| Myocardial Ischaemia |
0.5% |
| Prophylaxis |
0.5% |
| Type 2 Diabetes Mellitus |
0.5% |
| Drug Use For Unknown Indication |
0.5% |
| Pain |
0.5% |
| Thrombosis Prophylaxis |
0.5% |
| Hyperlipidaemia |
0.4% |
| Cardiac Disorder |
0.4% |
|
| Vision Blurred |
19.3% |
| Drug Ineffective |
15.8% |
| Therapeutic Response Decreased |
10.6% |
| Visual Impairment |
7.7% |
| Visual Acuity Reduced |
6.2% |
| Headache |
4.8% |
| Prostate Cancer |
4.0% |
| Visual Disturbance |
3.8% |
| Optic Ischaemic Neuropathy |
3.5% |
| Myalgia |
3.1% |
| Visual Field Defect |
2.5% |
| Wrong Technique In Drug Usage Process |
2.5% |
| Back Pain |
2.4% |
| Blindness |
2.3% |
| Tinnitus |
2.3% |
| Vomiting |
2.3% |
| Death |
2.0% |
| Priapism |
2.0% |
| Intentional Drug Misuse |
1.6% |
| Myocardial Infarction |
1.6% |
|
| Secondary |
| Erectile Dysfunction |
65.9% |
| Hypertension |
8.0% |
| Drug Use For Unknown Indication |
3.8% |
| Ill-defined Disorder |
3.1% |
| Product Used For Unknown Indication |
3.0% |
| Benign Prostatic Hyperplasia |
2.0% |
| Diabetes Mellitus |
1.6% |
| Anxiety |
1.5% |
| Depression |
1.2% |
| Blood Pressure |
1.1% |
| Gout |
1.1% |
| Prostatism |
1.1% |
| Blood Cholesterol Increased |
1.0% |
| Dyspepsia |
0.9% |
| Gastrooesophageal Reflux Disease |
0.9% |
| Micturition Urgency |
0.9% |
| Pulmonary Hypertension |
0.8% |
| Sleep Disorder |
0.8% |
| Type 2 Diabetes Mellitus |
0.8% |
| Back Pain |
0.7% |
|
| Drug Ineffective |
16.4% |
| Vision Blurred |
14.3% |
| Visual Impairment |
11.2% |
| Wrong Technique In Drug Usage Process |
7.8% |
| Visual Acuity Reduced |
6.8% |
| Prostate Cancer |
6.2% |
| Therapeutic Response Decreased |
6.0% |
| Tinnitus |
3.4% |
| Vomiting |
3.4% |
| Visual Disturbance |
3.1% |
| Headache |
2.9% |
| Spinal Disorder |
2.6% |
| Optic Ischaemic Neuropathy |
2.3% |
| Surgery |
2.3% |
| Hypertension |
2.1% |
| Rhinorrhoea |
2.1% |
| Syncope |
2.1% |
| Off Label Use |
1.8% |
| Weight Decreased |
1.8% |
| Malaise |
1.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
27.6% |
| Erectile Dysfunction |
11.2% |
| Drug Use For Unknown Indication |
9.2% |
| Hypertension |
7.4% |
| Pain |
5.1% |
| Multiple Sclerosis |
4.2% |
| Diabetes Mellitus |
4.1% |
| Blood Cholesterol Increased |
3.7% |
| Type 2 Diabetes Mellitus |
3.3% |
| Depression |
3.3% |
| Hiv Infection |
3.0% |
| Anxiety |
2.7% |
| Prophylaxis |
2.2% |
| Gastrooesophageal Reflux Disease |
2.1% |
| Parkinson's Disease |
2.0% |
| Atrial Fibrillation |
2.0% |
| Blood Testosterone Decreased |
1.8% |
| Psoriasis |
1.7% |
| Insomnia |
1.7% |
| Pulmonary Arterial Hypertension |
1.7% |
|
| Drug Ineffective |
10.4% |
| Pancreatitis |
6.3% |
| Progressive Multifocal Leukoencephalopathy |
6.3% |
| Weight Decreased |
6.3% |
| Myocardial Infarction |
5.8% |
| Vomiting |
5.8% |
| Erectile Dysfunction |
5.5% |
| Flushing |
5.1% |
| Nausea |
5.1% |
| Urticaria |
5.1% |
| Weight Increased |
4.8% |
| Headache |
4.6% |
| Vision Blurred |
4.3% |
| Prostate Cancer |
4.1% |
| Fatigue |
3.9% |
| Pain In Extremity |
3.6% |
| Transient Ischaemic Attack |
3.6% |
| Death |
3.4% |
| Paraesthesia |
3.1% |
| Pyrexia |
3.1% |
|
| Interacting |
| Erectile Dysfunction |
32.7% |
| Blood Cholesterol Increased |
10.2% |
| Benign Prostatic Hyperplasia |
6.1% |
| Glaucoma |
6.1% |
| Onychomycosis |
6.1% |
| Crohn's Disease |
4.1% |
| Diabetes Mellitus |
4.1% |
| Hypertension |
4.1% |
| Rheumatoid Arthritis |
4.1% |
| Abdominal Discomfort |
2.0% |
| Blood Cholesterol |
2.0% |
| Blood Pressure |
2.0% |
| Cardiac Disorder |
2.0% |
| Hyperlipidaemia |
2.0% |
| Hypertriglyceridaemia |
2.0% |
| Hyperuricaemia |
2.0% |
| Pain |
2.0% |
| Paraesthesia |
2.0% |
| Prostatomegaly |
2.0% |
| Sexual Dysfunction |
2.0% |
|
| Drug Interaction |
30.0% |
| Erectile Dysfunction |
10.0% |
| Lymphangitis |
6.7% |
| Pain In Extremity |
6.7% |
| Arthritis |
3.3% |
| Hypertension |
3.3% |
| Libido Decreased |
3.3% |
| Macular Degeneration |
3.3% |
| Malaise |
3.3% |
| Myalgia |
3.3% |
| Myocardial Infarction |
3.3% |
| Pain |
3.3% |
| Restlessness |
3.3% |
| Sciatica |
3.3% |
| Sleep Disorder |
3.3% |
| Tinnitus |
3.3% |
| Upper Motor Neurone Lesion |
3.3% |
| Visual Acuity Reduced |
3.3% |
|
